lecture 4 Flashcards

- that the properties of the host and the infectious agent determine the pathogenic consequences of infection - properties of H. pylori that contribute to disease - properties of the host that determine the outcome of H. pylori infection - pathogenesis of disease caused by infection of the gastrointestinal tract - treatment versus cure of disease

1
Q

What are the three main ways an infectious agent can cause disease?

A
  • contact with/entry into cells
  • toxin release - exotoxins/endotoxins/enzymes
  • induction of host responses - more damage e.g. suppuration, scarring, hypersensitivity (in some cases can be the main cause of disease).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the four basic microorganisms that cause disease.

A

Bacteria

  • 0.8-15 µm
  • prokaryotes (lack membrane bound nucleus)
  • single celled organism
  • intracellular or extracellular

Virus

  • 20-300nm
  • require host biosynthetic and replicative apparatus for proliferation
  • has to enter the cell

Fungi

  • 2-200µm
  • eukaryotes (distinct nucleus)
  • yeast or filamentous hyphae

Parasites

  • protozoa (1-50µm)
    • single celled eukaryotes
  • Helminths (3mm-10m)
    • parasitic worms (multicellular organisms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are resident flora?

A
  • not all microorganisms are pathogens
  • microorganisms that live on or within the body in non-sterile areas
    > skin
    > mucous membranes
    > GIT/bowel/rectum
    > vagina
  • not subject to inflammatory or immune attacks as long as skin and mucosa are intact
  • balance of homeostasis to prevent infection/disease
    • antibiotic use can change resident flora
    • immunocompromise (AIDS, organ transplant) can lead to opportunistic infection by normal flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a pathogen?

A

Disease-producing microbe

Disease is caused by

  • contact/entry
  • toxins
  • host immune response

Pathogenicity (capacity to cause disease) is determined by

  • virulence factors-determine how severe the disease is
  • invasiveness, ability to evade the immune system, speed of multiplication, production of toxins, adherence to host cell, degree of tissue damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What barriers are in place to block microbial invasion?

A

Mechanical

  • epithelial cells with tight junctions
  • air flow
  • movement of mucus by cilia
  • tears

Chemical

  • fatty acids
  • enzymes/peptides
  • pH
  • surfactant

Normal flora - provide competition in that niche

Eyes - tears

Respiratory tract

  • mucus
  • cilia

Digestive system

  • gastric acid
  • bile
  • enzymes
  • mucus
  • normal flora

skin

  • barrier
  • normal flora

urogenitory

  • flushing of urine
  • acidity of urine

vagina

  • pH
  • normal flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the morphology of a normal stomach

A

Stomach broken up into areas which have particular cells in them.

  • Cardia - mucin secreting cells, thick mucus material (at lower oesophageal sphincter)
  • Fundus - acid and enzyme secretion (top lobe) - stuff that breaks down food
  • (body) Corpus - acid and enzyme secretion
  • Antrum - gastrin and mucin secreting cells (just before it moves into the duodenum)
cross section: 
Longitudinal, circular, oblique muscles.
Submucosa
Muscularis mucosa 
Mucosa with epithelial cells and gastric pits that produce acids/enzymes that are required to digest food
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Do we get infection of the gastrointestinal tract?

A

The GIT:

  • hostile environment
  • acidic-secretion of hydrochloric acid: very low pH
  • mucosal barrier to prevent autodigestion
  • proteases
  • historically considered to be a sterile environment
  • however this environment can get disease e.g. chronic gastritis, peptic ulcer, gastric lymphoma, gastric adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is chronic gastritis?

A

Chronic inflammation of the stomach:
The presence of chronic mucosal inflammatory changes leading eventually to mucosal atrophy and epithelial metaplasia

Few symptoms… nausea, vomiting, upper abdominal discomfort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a peptic ulcer?

A
  • much more severe
  • Ulcer - breach in the mucosa of the alimentary tract, which extends through the muscularis mucosa into the submucosa or deeper
  • peptic ulcers occur in any part of the GIT exposed to acid/peptic juices
  • epigastric gnawing, burning, or aching pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is gastric cancer?

A

Gastric adenocarcinoma
- most common malignancy of the stomach representing 90% of all gastric cancers and a leading cause of cancer related death

Lymphoma

  • derived from mucosa associated lymphoid tissue (MALT therefore MALToma)
  • 5% of gastric malignancies are primary lymphomas
  • dense lymphocytic infiltrate within the lamina propria
  • chronic inflammation
  • low-grade B-cell lymphoma can become high-grade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the dogma of ‘no acid no ulcer’? How did this principle determine treatment and its outcomes?

A
  • the cause of peptic ulcers was always believed to be too much acid
  • if you can get rid of acid you won’t have ulcer
  • early treatment
    • targeted gastric acid secretion and mucosal defence mechanisms
  • – inhibition of gastric acid secretion by selective blocking of the proton pumps of parietal cells
  • – drugs that promote mucosal repair
  • successfully heal ulcer
  • ulcers tend to recur unless patient is maintained on acid suppression regime: drug company heaven - have to take my drugs forever
  • why? treating the symptom but not the cause of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When was the role of infection in GIT disease theorised?

A
  • 1984 paper published that stated:
    “The bacteria were present in almost all patients with active chronic gastritis, duodenal ulcer, or gastric ulcer and thus may be an important factor in the aetiology of these diseases”
  • considered that that infection may be important in the development of GIT disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which bacteria causes GIT disease?

A
  • Helicobacter pylori
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who were the pioneers in discovering the role of helicobacter?

A
  • 1892 - Italy - Giulio Bizzozero - noticed there were bacteria inside the stomach of dogs
  • 1940s - Ireland - Prof. Oliver Fitzgerald - in people who had peptic ulcers/chronic gastritis there was a predominance of/could detect enzyme called urease - particular to people who have this disease
  • 1958 - Greece - Dr. John Likoudis - gave himself antibiotics to treat a peptic ulcer and cured himself, also cured many people in the surrounding districts of peptic ulcers. Tried to extend his knowledge to the big cities of greece, “let’s do a clinical trial” - but the establishment was very much of the opinion “no acid, no ulcer” and so wasn’t able to get clinical trial up
  • 1970s - China - Professor Shu-Dong Xioa - regional doctor treating people with antibiotics, people from local region benefitted
  • 1982 - Dr Barry Marshall and Professor Robin Warren
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Who finally got the role of helicobacter recognised in the medical community and how?

A
  • Dr Barry Marshall and Professor Robin Warren
  • Nobel Prize for Physiology and Medicine 2005
  • for their discovery of “the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease”
  • who with tenacity and a prepared mind challenged prevailing dogmas
  • Barry Marshall infected himself with H.pylori - gave himself a nice case of gastritis - took antibiotics and cured disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the role of Helicobacter pylori in infection in GIT disease?

A
  • Chronic gastritis: strong causal
  • Peptic ulcer - strong causal - 1-10% of patients infected with H. pylori
  • Gastric Adenocarcinoma - strong causal - 0.1-3% of patients infected with H.pylori, first bacterium classified as a carcinogen
  • Gastric lymphoma - strong causal - <0.01% of patients infected with H. pylori
17
Q

Describe the epidemiology of H. pylori infection

A
  • Acquired-oral ingestion in early childhood
  • 20-50% industrialised countries (santitation/hygiene)
  • 80% developing countries
  • not all people with H. pylori have gastritis/ulcers but all (almost) patients with gastritis/ulcers have H. pylori infection - why?
18
Q

What determines who develops what disease?

A
  • Virulence of the H. pylori strain
  • Type and extent of the immune response
  • Modulation cofactors
    • genetic
    • environmental
19
Q

Describe helicobacter pylori

A
  • non-sporing curvilinear gram-negative rod
  • only human bacterium to persistently inhabit the gastric mucosa
  • uniquely adapted to stomach environment - gastric acid and mucus

motility:
- spiral shape and multiple flagella confer corkscrew motility

acid resistance:

  • urease (most abundant protein in H. pylori)
    • hydrolyses endogenous urea to ammonia and carbon dioxide
    • increases cytoplasmic pH
  • Buffers periplasm
  • chemotaxis
  • enables H. pylori to reside in mucous layer (more neutral pH)

adhesion

  • attached to but does not invade the gastric mucosa
  • most bacteria are free-swimming in the mucus, but a proportion is closely associated with the epithelial surface
  • attachment not essential but part of pathogenesis
20
Q

Describe the genetic diversity of Hp

A
  • Enormous genetic diversity
    • genetic drift
    • high mutation rate
    • natural transformation competence-exchange of DNA
21
Q

What is BabA?

A
  • blood group antigen-binding adhesion
  • facilitates adhesion to gastric epithelial cells
  • Cell notices that it has been bound to, and will respond: epithelial proliferation and inflammation
22
Q

What is Vac A ?

A
  • vacuolating cytotoxin
  • protein = 95kD
  • epithelial cell membrane, forms voltage-gated channel
  • forms hexameric pores, which are selective to anions and small neutral molecules, including urea
  • endocytosed and affect endosomal compartments (vacuoles) and mitochondria (cytochrome c release and apoptosis)
23
Q

What is the CagA gene?

A
  • cytotoxin-associated gene A
  • part of cag pathogenicity island
  • gene product (120-145 kD protein) strongly associated with peptic ulcer, gastric duodenal cancer
  • cag pathogenicity island:
    • large section of DNA that can be acquired by bacterial species
    • stains may be Cag+ or Cag-
    • contributes to pathogenicity
    • in some countries Cag+ strains are virtually ubiquitous
  • with Cag PI it is able to punch a hole into the cell, and through that put the CagA into the cell
  • CagA causes changes in cellular function, affects proliferation and epithelial barrier that can contribute to disease
  • can lead to proliferation and motility of the cell
  • affect cytoskeleton
  • induce apoptosis
  • cause faulty apical junctional complex allowing for paracellular leakage
24
Q

What is the host response to H-pylori infection?

A
  • All H. pylori strains induce a marked immune response
  • Host immune response is generally ineffective in clearing the infection
  • H. pylori has developed methods to evade immune response
    • changes in LPS and flagellin (PAMPS) reduced recognition by innate immune response (PRR/TLR)
    • inhibit NO production by macrophages
    • enzymes that combat bactericidal oxidative stress
  • immune response is important to pathogenesis
  • inflammation is greater in strains that express specific virulence factors
  • infection with H. pylori will give you a chronic inflammatory response
25
Q

What is the specific immune response and pathogenesis?

A
  • H. pylori is an extracellular pathogen
  • induces a strong humoral immune response
  • should result in Th2-cell help
  • but response is generally Th1-cell - skewing of immune response
26
Q

What is the pathogen-host interaction?

A
  • if you end up with a Th-1 response you will end up with a severe chronic gastritis because it is not as effective at clearing the infection
  • Th-2 = mild gastritis
27
Q

How does H. pylori contribute to the development of peptic ulcer?

A
  • depends on whether you can maintain the balance of defensive forces against damaging forces
  • Hp increases susceptibility to peptic ulcer
  • disruption of gastric and duodenal mucosal defences vs.
  • gastric acidity
28
Q

What is peptic ulcer disease?

A
  • degradation of the epithelial layer below the mucosa
29
Q

What are the consequences of severe gastritis?

A
  • if you have inflammation in the body corpus - these are the cells that produce acid, so damaging these cells will result in less acid production –> gastric atrophy –> more likely to get gastric ulceration
  • in contrast: if gastritis is down in the antrum - more acid in stomach - these are not the cells that produce acid - ulcers tend to be in duodenum
30
Q

Describe gastric ulcers caused by H. pylori infection

A
  • associated with pan gastric inflammation
  • reduced or normal acid secretion
  • dense colonisation and inflammation
  • H. pylori compromises mucosal defenses leading to epithelial damage
31
Q

Describe duodenal ulcers caused by H. pylori infection

A
  • inflammation of the gastric mucosa in non-acid secreting antral region of the stomach
  • increased stimulation of acid secretion from the less affected proximal acid secreting fundus mucosa
  • may cause gastric metaplasia into duodenum in response to increased acid (enabling H. pylori colonisation)
32
Q

What are the consequences of H. pylori infection?

A
  • High acid = duodenal ulcer
  • corpus predominant = gastric ulcer
  • further consequences = cancer
33
Q

How does H. pylori infection cause gastric cancer?

A

Gastric adenocarcinoma

  • epithelial proliferation in the background of chronic inflammation
  • pangastric or corpus-predominant gastritis
  • associated with gastric atrophy and intestinal metaplasia
  • carcinogenesis associated with gastric atrophy
    • reactive oxygen and nitrogen species associated with inflammation
    • possibly other bacteria within the the now achlorhydric stomach

Gastric lymphoma

  • normal stomach does not have Mucosa-associated lymphoid tissue (MALT)
  • MALT acquisition depends on infection with helicobacter species
  • Transformation into low-grade extra-nodal B cell lymphoma
    • direct antigen stimulation by H. pylori
    • mutations caused by oxidative damage
34
Q

What host genetic factors are involved in predisposing to gastric cancer?

A
  • host pro-inflammatory cytokine variations predispose to adenocarcinoma
  • cytokine gene polymorphisms
    • IL-I gene cluster
  • innate immune response gene polymorphisms
    • TLR
  • HLA polymorphisms
35
Q

What are some other causes of peptic ulcer disease?

A
  • not all people with H pylori have gastritis/ulcers but all (almost) patients with gastritis/ulcers have H.pylori infection
  • gastric hyperacidity - strongly ulcerogenic
  • chronic use of non-steroidal anti-inflammatry drugs especially aspirin
  • use of corticosteroids
  • tobacco smoking
    • impairs mucosal blood flow
    • affects healing
  • alcohol - peptic ulcers
36
Q

What is the treatment and prevention of the disease?

A
  • the goal for people with H. pylori is complete eradication (cure)
  • antibiotics + proton pump inhibitor to reduce acidity
  • challenges:
    • antibiotic efficacy in acidic environment
    • effective vaccine development and induction of effective immune response
    • the role of H. pylori infection in other disease
    • gastroesophageal reflux disease